Jeffrey A. Cerny
Analyst · Barclays
Thanks, Bilal. Turning to our fourth quarter results, our investment portfolio totaled $312.2 million on a fair value basis as of December 31, equating to 99.6% of cost. The investment portfolio was comprised of 62 companies, 36 in the senior loan fund and 26 in the SBIC fund. As a percentage of fair value at quarter-end, our investments were comprised of approximately 77% in senior secured loans, 17% in subordinated debt and 6% in equity. At December 31, the 62 companies in our portfolio were diversified across 19 industries. Our largest portfolio company accounted for 4.7% of the aggregate fair value of our portfolio. Additionally, our five largest investments accounted for approximately 22% of the portfolio's total fair value. Our average investment in each portfolio company was approximately $5 million at fair value or 1.6% of the portfolio’s total fair value. The weighted average yield to fair value on our debt investments was approximately 9.56% versus 9.09% as of September 30. This 47 basis point pickup in weighted average yield to fair value quarter-over-quarter reflects the continued ramp-up in our SBIC fund. On a fair value basis at December 31, the debt investments in the SBIC fund now represent approximately 60% of the debt portfolio versus 47% last quarter. The weighted average yield to fair value was 6.6% and debt investments in our senior loan fund and 11.6% on debt investments in our SBIC fund. As Bilal mentioned our intention is to continue to redeploy equity capital from our senior loan fund into higher-yielding assets. Our one non-accrual investment which I will discuss momentarily was omitted from the weighted average yield to fair value calculation. At the end of the fourth quarter, floating rate loans comprised 73% of our loan portfolio this is down from 82% last quarter, largely driven by the growth in our SBIC portfolio. Certain unit tranche and subordinated debt investments which are more common in the SBIC fund tend to be structured with fixed rates. All of our floating rate loans contain LIBOR floors. As I noted earlier we had one non-accrual loan at December 31st, our debt investment in Strata Pathology Services. It had a fair value of $801,000 at year end and has been on non-accrual since the first quarter of 2013. Moving on to deal activity, during the fourth quarter, we closed transactions with 10 portfolio companies with an aggregate principal amount of $72.6 million. This included $70.7 million of investments in nine new portfolio companies and $1.9 million of follow-on investments. These investments included senior secured loans, subordinated loans, preferred stock, common ownership interest and warrants with approximately 94% constituting loan investments. We also sold one $7 million loan from our SBIC fund at 102% of par, versus its 98.3% fair value at September 30. This was a LIBOR plus 750 assets and was one of the lower yielding loans in the SBIC fund. We believe the 102% sales price we negotiated was a very good outcome for this loan. We derived approximately $6.9 million in total investment income in the fourth quarter compared with $6.2 million in the third quarter. The improvement was largely due to a strong quarter of new investments in the SBIC fund, which was partially offset by prepayments and amortization in the senior loan fund and a 47 basis point increase in the weighted average yield to fair value quarter-over-quarter. Approximately $2.3 million of the fourth quarter’s total investment income was derived from our senior loan fund, and $4.6 million came from our SBIC fund. The percentage of total investment income derived from our SBIC fund made up 67% versus 56% in the prior quarter. Again, this highlights our efforts to optimize our portfolio into higher yielding investments. Expenses totaled $4.2 million for the fourth quarter compared with $3.3 million for the prior quarter. It is important to note that this $900,000 increase in expenses was largely driven by a $665,000 non-cash write-off of deferred financing closing costs related to our voluntary commitment reduction of our senior loan fund debt facility. Such reduction was initiated to reduce unused line fees as we shrink the senior loan fund portfolio. The remaining increase in expense was mostly attributable to an increase in interest expense as we finance our asset growth. In the aggregate, the total amount of our administrative fee, professional fees, and general and administrative expenses was largely unchanged in the fourth quarter compared with the prior quarter. Net investment income for the fourth quarter was approximately $2.7 million or $0.28 per share, compared with $2.9 million or $0.30 per share in the prior quarter. Again, it is important to note that net investment income was reduced by a non-cash write-off of $665,000 related to our voluntary debt facility commitment reduction. Our adjusted net investment income was $3.1 million or $0.33 per share excluding that non-cash write-off, but adding back $265,000 in additional incentive fees, we would have paid in the absence of such write-off. We believe this adjusted net investment income of $0.33 per share which is a non-GAAP measure provides greater transparency into our ongoing operations. We expect to continue presenting this non-GAAP adjusted net investment income amount in the future as we are likely to incur additional non-cash charges related to reductions in our senior loan fund debt facility. The facility reductions will be determined as we continue our efforts to shift our equity capital towards supporting higher yielding assets. For the fourth quarter, we had a net increase in net assets resulting from operations of $3.5 million or $0.36 per share compared with $3.8 million or $0.40 per share for the third quarter. Again, I would like to highlight that this quarters net increase and net assets resulting from operations was reduced by the non-cash write-off I previously discussed. As noted on our last earnings call, we received SBA approval for the remaining leverage in our existing SBIC fund. As of today, we have capacity to make additional investments in our existing SBIC fund of approximately $43.6 million, which includes $22.6 million in incremental SBA debenture borrowing capacity. Also, as Bilal mentioned we did file with the SBA to obtain a second SBIC license. With that, I'll turn the call back over to Bilal.